Related Experiment Video
Updated: Dec 9, 2025

Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag
Published on: December 14, 2017
Roles of lysosomotropic agents on LRRK2 activation and Rab10 phosphorylation
Tomoki Kuwahara1, Kai Funakawa1, Tadayuki Komori1
1Department of Neuropathology, Graduate School of Medicine, The University of Tokyo, Tokyo 113-0033, Japan.
Abstract:
Leucine-rich repeat kinase 2 (LRRK2), the major causative gene product of autosomal-dominant Parkinson's disease, is a protein kinase that phosphorylates a subset of Rab GTPases. Since pathogenic LRRK2 mutations increase its ability to phosphorylate Rab GTPases, elucidating the mechanisms of how Rab phosphorylation is regulated by LRRK2 is of great importance. We have previously reported that chloroquine-induced lysosomal stress facilitates LRRK2 phosphorylation of Rab10 to maintain lysosomal homeostasis. Here we reveal that Rab10 phosphorylation by LRRK2 is potently stimulated by treatment of cells with a set of lysosome stressors and clinically used lysosomotropic drugs. These agents commonly promoted the formation of LRRK2-coated enlarged lysosomes and extracellular release of lysosomal enzyme cathepsin B, the latter being dependent on LRRK2 kinase activity. In contrast to the increase in Rab10 phosphorylation, treatment with lysosomotropic drugs did not increase the enzymatic activity of LRRK2, as monitored by its autophosphorylation at Ser1292 residue, but rather enhanced the molecular proximity between LRRK2 and its substrate Rab GTPases on the cytosolic surface of lysosomes. Lysosomotropic drug-induced upregulation of Rab10 phosphorylation was likely a downstream event of Rab29 (Rab7L1)-mediated enzymatic activation of LRRK2. These results suggest a regulated process of Rab10 phosphorylation by LRRK2 that is associated with lysosomal overload stress, and provide insights into the novel strategies to halt the aberrant upregulation of LRRK2 kinase activity.
Insights
Lysosomal stress, induced by drugs, enhances Leucine-rich repeat kinase 2 (LRRK2) phosphorylation of Rab GTPases. This process, linked to Parkinson's disease, involves LRRK2 recruitment to lysosomes and Rab29 activation, offering new therapeutic insights.
Area of Science:
- Neuroscience
- Cell Biology
- Biochemistry
Background:
- Leucine-rich repeat kinase 2 (LRRK2) is a key protein kinase implicated in Parkinson's disease pathogenesis.
- LRRK2 phosphorylates Rab GTPases, and mutations associated with Parkinson's disease enhance this activity.
- Previous work showed chloroquine-induced lysosomal stress promotes LRRK2-Rab10 phosphorylation for lysosomal homeostasis.
Purpose of the Study:
- To investigate how lysosomal stress and lysosomotropic drugs regulate LRRK2-mediated Rab GTPase phosphorylation.
- To elucidate the mechanisms underlying the enhanced LRRK2 activity under lysosomal stress conditions.
- To explore potential therapeutic strategies targeting LRRK2 dysregulation in Parkinson's disease.
Main Methods:
- Cellular treatment with various lysosome stressors and clinically used lysosomotropic drugs.
- Analysis of LRRK2 localization, Rab10 phosphorylation levels, and LRRK2 autophosphorylation (Ser1292).
- Assessment of cathepsin B release and LRRK2-Rab GTPase proximity on lysosomes.
- Investigation of the role of Rab29 (Rab7L1) in mediating LRRK2 activation.
Main Results:
- Lysosomotropic drugs and lysosomal stressors potently stimulate LRRK2 phosphorylation of Rab10.
- These agents induce LRRK2 recruitment to enlarged lysosomes and promote cathepsin B release.
- LRRK2 kinase activity (Ser1292 autophosphorylation) was not increased, but LRRK2-Rab proximity on lysosomes was enhanced.
- Rab10 phosphorylation upregulation is downstream of Rab29-mediated LRRK2 activation.
Conclusions:
- LRRK2-mediated Rab10 phosphorylation is tightly regulated by lysosomal overload stress.
- Lysosomotropic drugs enhance LRRK2-Rab GTPase interaction on lysosomes, independent of increased LRRK2 enzymatic activity.
- Rab29 plays a crucial role in mediating LRRK2 activation under lysosomal stress.
- Findings suggest novel strategies to modulate aberrant LRRK2 kinase activity in Parkinson's disease.
More Related Videos
12:49Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 Phosphorylation
Published on: March 21, 2020
11:31Metabolic Labeling of Leucine Rich Repeat Kinases 1 and 2 with Radioactive Phosphate
Published on: September 18, 2013
Related Concept Videos
Lysosomal Hydrolases
PI3K/mTOR/AKT Signaling Pathway
Rab Proteins
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
Rab Cascades
Amplifying Signals via Enzymatic Cascade
Receptor Tyrosine Kinases